Tag: US cannabis

April 20, 2020

CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates

CB2 Insights (CSE:CBII; OTCQB: CBIIF) has completed the terms of the purchase agreement of Colorado-based Rae of Sunshine Health Services.
April 15, 2020

CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief Under COVID-19 Duress

CB2 Insights (CSE:CBII), has announced that due to circumstances created by the COVID – 19 pandemic, it will not be...
March 30, 2020

CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

Free interactive tool allows industry players to gain immediate insights derived from CB2 Insights aggregated and anonymized clinical outcome data.
February 26, 2020

Orchid Ventures Announces The Launch Of A New Subsidiary, PurTec Delivery Systems, A Delivery System Technology Company

Multi-State cannabis company Orchid Ventures, Inc. announces the launch of a new subsidiary, PurTec Delivery Systems, LLC.
January 29, 2020

CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors

CB2 Insights is pleased to announce the appointment of Tom Brogan, as an independent director to CB2’s Board of Directors.
January 28, 2020

CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine

CB2 Insights announces it has completed all payment obligations for the June 2019 acquisition of New Jersey Alternative Medicine.
January 22, 2020

Orchid Ventures Announces Termination to Acquire Pure Dispensaries, LLC

Orchid Ventures and Pure Dispensaries mutually agreed to terminate the Stock Purchase Agreement to acquire 100% of the interest of...